Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bioengineered Replacement Ears Look, Behave Like the Original

By LabMedica International staff writers
Posted on 05 Mar 2013
Physicians have effectively constructed a duplicate of a living human ear that appears and acts the same as the real thing. More...
Researchers believe their bioengineering technology will be effective in the long search by scientists and physicians to provide normal looking “new” ears to children born with congenital ear deformities.

In their study, published February 20, 2013, in the journal PLOS ONE, the researchers revealed how three-dimensional (3D) printing and new injectable gels made of living cells can be used to fashion ears that are identical to a human ear. Over a three-month period, the length of the study, these flexible ears progressively grew cartilage to replace the collagen that was used to help mold them.

“I believe this will be the novel solution reconstructive surgeons have long wished for to help children born with absence or severe deformity of the ear,” said the study’s co-lead author, Dr. Jason Spector, director of the Laboratory for Bioregenerative Medicine and Surgery (LBMS) and associate professor of surgery of plastic surgery in the department of surgery at Weill Cornell Medical College (New York, NY, USA), and an adjunct associate professor in the department of biomedical engineering at Cornell University (Ithaca, NY, USA). A bioengineered ear replacement like this would also help individuals who have lost part or all of their external ear in an accident or from cancer.”

Replacement ears are now constructed using compounds that have a Styrofoam-like consistency, or sometimes, surgeons will build ears from rib that is harvested from a young patient. “This surgical option is very challenging and painful for children, and the ears rarely look totally natural or perform well,” stated Dr. Spector, who is also a plastic and reconstructive surgeon at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. “All other attempts to ‘grow’ ears in the lab--including one 1997 study widely publicized by photos of ears implanted on the backs of mice—have failed in the long term.”

This Cornell bioengineered ear is the best to date in appearing and acting like a natural ear, the researchers reported. Moreover, the process of making the ears is fast—it takes only one week at most. “This is such a win-win for both medicine and basic science, demonstrating what we can achieve when we work together,” said the study’s other lead author, Dr. Lawrence J. Bonassar, associate professor and associate chair of the department of biomedical engineering at Cornell University.

The deformity that both Dr. Spector and Dr. Bonassar are trying to remedy is microtia, a congenital deformity in which the external ear is not fully developed. Dr. Spector and Dr. Bonassar have been collaborating on bioengineered human replacement parts since 2007, and Dr. Bonassar has also been working with other Weill Cornell physicians. For example, he and Weill Cornell’s neurologic surgeon Dr. Roger Härtl are currently testing bioengineered disc replacements using some of the same methods demonstrated in this current study. The researchers specifically work to develop replacements for human structures that are primarily made of cartilage—spine, nose, joints, trachea—because cartilage does not need to be vascularized with a blood supply in order to survive.

To make the ears, Dr. Bonassar and his colleagues first took a combination laser scan and panoramic photo of an ear from twin girls, which provided a digitized 3D image of their ears on a computer screen. That took 30 seconds, and did not involve any ionizing radiation. The researchers then converted that image into a digitized “solid” ear and used a 3D printer to build a mold of the ear. The researchers noted that the mold is similar to a box with a hole in the middle that is in the shape of the mirror image of the ear.

The scientists injected animal-derived collagen into that ear mold, and then added almost 250 million cartilage cells. The collagen acted as a scaffold upon which cartilage could grow. Collagen is the chief structural protein in the body of every mammal. Animal-based collagen is frequently used for cosmetic and plastic surgery. This high-density collagen gel, which Cornell researchers developed, looks similar to flexible Jell-O [a gelatin dessert] when the mold is removed.

“The process is fast,” Dr. Bonassar said. “It takes half a day to design the mold, a day or so to print it, 30 minutes to inject the gel and we can remove the ear 15 minutes later. We trim the ear and then let it culture for several days in a nourishing cell culture medium before it is implanted.”

During the three-month observation period, the cartilage in the ears grew to replace the collagen scaffold. “Eventually, the bioengineered ear contains only auricular cartilage, just like a real ear,” remarked Dr. Spector. Dr. Spector reported that if all future safety and effectiveness testing work out, it might be possible to try the first human implant of a Cornell bioengineered ear in as a short time as three years. “The innovation in this study is two-fold,” stated Dr. Bonassar. “The use of imaging technology to rapid and accurately make the shape of the ear implant is new, as is the high-density collagen gel for the mold.”

“These bioengineered ears are highly promising because they precisely mirror the native architecture of the human ear,” Dr. Spector concluded. “They should restore hearing and a normal appearance to children and others in need. This advance represents a very exciting collaboration between physicians and basic scientists. It is a demonstration of what we hope to do together to improve the lives of these patients with ear deformity, missing ears, and beyond.”

Related Links:
Weill Cornell Medical College


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.